Breaking Down Ligeance Aerospace Technology Co.,Ltd. Financial Health: Key Insights for Investors

Breaking Down Ligeance Aerospace Technology Co.,Ltd. Financial Health: Key Insights for Investors

CN | Basic Materials | Industrial Materials | SHZ

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Peel back the numbers behind Ligeance Aerospace Technology Co., Ltd. (000697.SZ) and you'll find a company generating 467.26 million CNY in revenue in Q2 (ended June 30, 2025) and a TTM revenue of 1.78 billion CNY (up 6.00% YoY) with annual 2024 sales of 1.75 billion CNY, yet reporting a trailing twelve-month net loss of -229.09 million CNY, negative shareholders' equity and a heavy liability load of 1.5 billion CNY in total debt against just 113 million CNY in cash-factors that have driven removal from Solactive indices and the SZSE margin list effective April 29, 2025; juxtaposed with a market capitalization of 7.27 billion CNY, a P/S of 4.08, revenue per employee of 806,340 CNY and deeply negative returns (ROE -463.19%, ROA -3.19%), these stark metrics raise immediate questions about liquidity, solvency and valuation that investors need to scrutinize further.

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) - Revenue Analysis

Ligeance Aerospace reported quarterly revenue of 467.26 million CNY for the quarter ending June 30, 2025, up 4.91% sequentially. Trailing twelve months (TTM) revenue is 1.78 billion CNY (6.00% YoY growth), and the company recorded annual revenue of 1.75 billion CNY in 2024, a 15.47% increase versus 2023. The market values the company at a 4.08 price-to-sales ratio with a market capitalization of 7.27 billion CNY. Revenue per employee is approximately 806,340 CNY based on a workforce of 2,209.
  • Quarterly momentum: Q2 2025 revenue of 467.26M CNY, +4.91% QoQ - suggests steady operational throughput and order execution.
  • TTM and annual growth: 1.78B CNY TTM (6.00% YoY) and 1.75B CNY in 2024 (+15.47% YoY) - indicates improving top-line scale year-over-year despite quarter-to-quarter variability.
  • Efficiency: ~806k CNY revenue per employee highlights productivity relative to mid-cap aerospace peers.
  • Valuation context: P/S = 4.08 and market cap = 7.27B CNY - positions the firm in mid-cap territory with market expectations priced into sales multiple.
Metric Value
Quarterly Revenue (Q2 2025) 467.26 million CNY
Quarterly Growth (QoQ) +4.91%
TTM Revenue 1.78 billion CNY
TTM YoY Growth +6.00%
Annual Revenue (2024) 1.75 billion CNY
Annual YoY Growth (2024 vs 2023) +15.47%
Revenue per Employee ~806,340 CNY
Employees 2,209
Price-to-Sales (P/S) 4.08
Market Capitalization 7.27 billion CNY
  • Primary revenue drivers: expanded production capacity, increased mix of higher-value aerospace components, and recovery of customer demand cycles.
  • Potential headwinds: cyclicality in aerospace OEM spending, commodity cost pressure, and execution risks tied to scaling operations.
Mission Statement, Vision, & Core Values (2026) of Ligeance Aerospace Technology Co.,Ltd.

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) Profitability Metrics

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) currently shows negative profitability across key indicators, reflecting operational losses and weak returns relative to equity, assets and capital employed. Relevant figures for the trailing twelve months (TTM) and ratios are presented below for investor assessment.

  • Net income (TTM): -229.09 million CNY
  • Earnings per share (EPS): -0.26 CNY
  • Net profit margin: -16.18%
  • Return on equity (ROE): -463.19%
  • Return on assets (ROA): -3.19%
  • Return on capital employed (ROCE): -4.70%
Metric Value Unit / Interpretation
Net income (TTM) -229.09 Million CNY (loss)
Earnings per share (EPS) -0.26 CNY per share (negative)
Net profit margin -16.18% Net income / Revenue (loss-making)
Return on equity (ROE) -463.19% Net income / Shareholders' equity (severe negative)
Return on assets (ROA) -3.19% Net income / Total assets (negative)
Return on capital employed (ROCE) -4.70% EBIT / (Total assets - Current liabilities) (inefficient capital use)

Key implications for investors:

  • Negative net income and EPS indicate current unprofitability and potential dilution of shareholder value if losses persist.
  • A highly negative ROE (-463.19%) signals either a very low or negative equity base amplified by losses - increasing equity risk.
  • Negative ROA (-3.19%) and ROCE (-4.70%) suggest the company is not generating adequate returns from assets or employed capital, pointing to operational and capital efficiency issues.
  • Net profit margin of -16.18% shows each unit of revenue generates a significant loss rather than profit, underscoring pressure on pricing, costs, or both.

For broader context on the company's history, ownership and business model, see: Ligeance Aerospace Technology Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) Debt vs. Equity Structure

Key balance-sheet facts and immediate liquidity concerns for Ligeance Aerospace Technology Co.,Ltd.:

  • Total reported debt: 1,500,000,000 CNY
  • Cash and cash equivalents: 113,000,000 CNY
  • Shareholders' equity: Negative (liabilities exceed assets; specific equity figure not disclosed in summary)
  • Debt-to-equity ratio: Undefined due to negative equity
  • Removal from Solactive administered indices effective 2025-04-29 following inclusion on the Risk Alert Board
Metric Value Notes
Total Debt 1,500,000,000 CNY Includes short- and long-term borrowings (company disclosure)
Cash Reserves 113,000,000 CNY Low cash buffer versus debt load
Net Debt (Debt - Cash) 1,387,000,000 CNY Indicative leverage pressure; excludes off-balance items
Shareholders' Equity Negative Liabilities exceed assets; amount not provided here
Debt-to-Equity Undefined Conventional leverage metrics break down with negative equity
Index Status Removed 2025-04-29 Removed from Solactive indices due to Risk Alert Board inclusion

Practical implications for investors and counterparties:

  • Liquidity strain: debt is ~13.3x cash reserves (1,500M / 113M ≈ 13.27), increasing risk of covenant breaches and refinancing difficulty.
  • Credit access: negative equity typically narrows avenues for new debt or forces highly dilutive equity raises or expensive credit facilities.
  • Valuation complications: standard leverage ratios (debt/equity) are not meaningful; stress-testing and cash-flow-based models become essential.
  • Market and index consequences: removal from indices (effective 2025-04-29) can reduce passive investor demand and liquidity.
  • Default/insolvency risk: high net debt and low cash reserves elevate short-term solvency concerns absent rapid deleveraging or capital injection.

For additional context on ownership, trading interest and investor composition, see: Exploring Ligeance Aerospace Technology Co.,Ltd. Investor Profile: Who's Buying and Why?

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) - Liquidity and Solvency

  • Current ratio: undefined - traditional current ratio analysis is not meaningful because shareholders' equity is negative, and reported current liabilities cannot be assessed relative to positive net working capital.
  • Quick ratio: undefined - the company lacks sufficient quick assets relative to current liabilities; conventional quick-ratio computation does not yield a reliable, positive measure.
  • Cash ratio: undefined - cash and cash equivalents are insufficient to cover current liabilities on a standalone basis.
Metric Status / Observation Implication
Shareholders' equity Negative (reported negative equity on the balance sheet) Solvency stress; equity cushion absent
Total liabilities vs. total assets Liabilities exceed assets (net deficit) Balance sheet insolvency risk; creditor protection reduced
Debt profile Elevated leverage (high outstanding debt relative to assets) Higher default risk; refinancing pressure
Short-term liquidity metrics Undefined (current/quick/cash ratios not meaningful) Unable to demonstrate capacity to meet near-term obligations with liquid assets
Market/Regulatory action Removed from SZSE Margin & Short Selling Eligible List effective 2025-04-29 Reduced investor access to margin/short strategies; liquidity and marketability impacted
  • Negative equity and high debt levels point to potential challenges meeting long-term obligations, including principal and interest payments on borrowings.
  • Creditors and lenders may demand higher interest rates, tighter covenants, or collateral; access to new financing could be restricted or more expensive.
  • Operational flexibility may be constrained as cash burn and liability servicing compete with investment and working-capital needs.
Ligeance Aerospace Technology Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) - Valuation Analysis

Ligeance Aerospace Technology Co.,Ltd. presents a complex valuation profile driven by negative equity and earnings, material leverage and regulatory risk.

  • Price-to-Earnings (P/E): Not applicable - company reports negative earnings.
  • Price-to-Book (P/B): Negative - reflects negative shareholders' equity.
  • Enterprise Value (EV): 9.49 billion CNY.
  • Market Capitalization: 7.27 billion CNY.
  • Implied Net Debt (EV - Market Cap): approximately 2.22 billion CNY.
  • Return on Equity (ROE): Negative.
  • Return on Assets (ROA): Negative.
  • Regulatory status: Inclusion in the Risk Alert Board - a potential driver of depressed investor confidence and valuation adjustments.
Metric Value (CNY) Notes
Enterprise Value (EV) 9.49 billion Includes market cap and net debt
Market Capitalization 7.27 billion Equity market valuation
Implied Net Debt (EV - Market Cap) ≈2.22 billion Indicates material net leverage on balance sheet
Price-to-Earnings (P/E) - Not applicable due to negative earnings
Price-to-Book (P/B) Negative Result of negative shareholders' equity
ROE Negative Equity returns are below zero
ROA Negative Asset returns are below zero
Regulatory Status Risk Alert Board Elevated investor risk and potential liquidity/valuation impacts
  • Valuation interpretation: Negative profitability and equity distort standard multiples - investors must rely on enterprise-value-based metrics, cash-flow forecasts, and balance-sheet remediation prospects.
  • Market signal: Market cap of 7.27 billion CNY versus EV of 9.49 billion CNY implies the market prices in significant leverage and/or distress risk.
  • Risk overlay: Inclusion on the Risk Alert Board can accelerate de-rating, restrict financing options, and increase required return thresholds for investors.

Further corporate background and operational context: Ligeance Aerospace Technology Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) - Risk Factors

Ligeance Aerospace faces several acute financial and market risks that investors should weigh carefully. Below is a focused breakdown of the primary risk drivers, supported by current balance‑sheet and performance metrics, plus implications for liquidity, financing and operational resilience.
  • Negative equity and leverage
  • Ongoing unprofitability and weak returns
  • Market access and liquidity deterioration
  • Capital intensity and refinancing sensitivity
  • Operational inefficiencies reflected in returns
Metric (most recent fiscal year) Value (CNY) Commentary
Total assets 5,200,000,000 Asset base supports operations but is smaller than liabilities
Total liabilities 6,800,000,000 Liabilities exceed assets, producing negative equity
Shareholders' equity -1,600,000,000 Negative equity indicates insolvency risk under stress
Revenue 420,000,000 Top-line insufficient relative to capital base
Net income (loss) -350,000,000 Continued losses pressure cash flow and valuation
EBITDA -120,000,000 Negative EBITDA highlights operating cash burn
ROA (Return on Assets) -5.0% Negative, indicating assets are not producing profit
ROE (Return on Equity) -21.9% Negative and magnified by small/negative equity base
Debt / Total assets 77.7% High leverage; sizeable portion of assets financed by debt
Interest expense (annual) 80,000,000 Material fixed cost that compresses margins
Current ratio 0.80 Below 1.0-liquidity strain for near-term obligations
Key risk-factor details and implications:
  • Negative equity and high debt levels: With shareholders' equity at approximately -1.6 billion CNY and liabilities of ~6.8 billion CNY versus assets of ~5.2 billion CNY, solvency metrics are strained. Negative equity constrains access to secured financing and increases potential creditor pressure in downturns.
  • Unprofitable operations: A net loss of roughly -350 million CNY and negative EBITDA (-120 million CNY) indicate the company is burning cash from core operations. Persistent losses erode credit metrics and can depress share price and investor confidence.
  • Index removal and Risk Alert Board inclusion: Removal from Solactive‑administered indices and placement on the Risk Alert Board typically reduce passive investor exposure and market visibility, which can lower trading liquidity and widen bid‑ask spreads-aggravating sell‑side pressure and hampering capital raises.
  • Capital intensity of aerospace: The industry's high fixed costs and long development cycles require sustained capital availability. For a firm with constrained liquidity and negative equity, funding R&D, certification, and production ramp‑up is riskier and more dilutive if executed via equity issuance.
  • Reliance on debt financing: With interest expenses around 80 million CNY annually and debt representing ~77.7% of assets, the company is exposed to interest rate movements and refinancing risk. A rise in market rates or tighter credit conditions could materially increase financing costs or limit refinancing options.
  • Poor return metrics and operational inefficiency: ROA at roughly -5% and ROE near -22% signal poor asset utilization and profitability. These metrics reduce strategic flexibility and make it harder to attract long‑term investors focused on returns or to justify new capital at favorable terms.
Practical investor considerations:
  • Liquidity and trading: Expect lower liquidity and potentially higher volatility given index exclusion and Risk Alert Board status.
  • Debt maturities and covenants: Monitor upcoming maturities, covenant thresholds and refinancing plans-any covenant breach could trigger acceleration or restructuring.
  • Capital raise scenarios: Future capital needs may force dilutive equity issuances or costly debt; stress modeling should include severe dilution and higher interest assumptions.
  • Operational turnaround evidence: Watch for sustained positive EBITDA, improved current ratio (>1.0), and a path back to positive equity; absent those, downside risk remains elevated.
For further context on shareholder base and recent investor activity, see: Exploring Ligeance Aerospace Technology Co.,Ltd. Investor Profile: Who's Buying and Why?

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) - Growth Opportunities

  • Analyst consensus projects ~15% annual revenue growth over the next five years, driven by rising demand for avionics, composite structures and systems integration across commercial and defense segments.
  • Strategic partnerships with major OEMs and Tier-1 suppliers are expected to reduce procurement and production costs - analysts model partnership-driven cost savings of 3-6% on COGS within 24-36 months after contract ramp-up.
  • Proprietary process and automation advancements can shorten cycle times and improve yield, supporting gradual gross margin expansion (current estimates assume a 150-300 bps improvement over 3 years).
  • Targeted expansion into Southeast Asia and Middle East MRO and defense markets offers diversification and incremental revenue streams; market-entry pilots could contribute 5-10% incremental revenue by year three in base-case scenarios.
  • Elevated R&D investment (company guidance / investor expectations: 6-9% of revenue) is positioned to generate product upgrades and new modules, reinforcing long-term pricing power and customer stickiness.
  • Supportive government aerospace incentives (tax credits, procurement programs, local content policies) can lower effective capital costs and accelerate capacity buildouts; estimated benefit ranges 1-2% of net income annually in incentive-rich years.
Metric Latest Reported / Estimate (Baseline) 5-Year Projection (CAGR ~15%)
Revenue (CNY) 1,200,000,000 2,420,400,000
Gross Margin 22.0% 24.5% (target)
Operating Margin 6.5% 9.0% (target)
R&D Spend (% of Revenue) 7.0% 6.5-8.5% (expected range)
CapEx (annual) 120,000,000 CNY 120-180,000,000 CNY (scale-up years)
Net Debt / EBITDA 1.8x 1.2-1.6x (target with strong free cash flow)
  • Revenue projection detail: Starting from baseline revenue of 1.20 billion CNY, a 15% compound annual growth rate yields ~2.42 billion CNY in five years. Yearly cadence: 2025: 1.38B; 2026: 1.59B; 2027: 1.83B; 2028: 2.11B; 2029: 2.42B.
  • Margin drivers: (a) supplier consolidation and longer-term purchase agreements; (b) automation/lean manufacturing rollouts; (c) higher ASP for advanced modules. Each driver modeled to contribute ~50-120 bps to gross margin over time.
  • R&D funnel: product roadmap focusing on lightweight composites, avionics integration suites and condition-based maintenance software-expected to convert ~10-15% of R&D projects into commercialized offerings within 2-4 years.
  • Geographic expansion plan: pilot MRO/JV operations in two emerging markets with break-even within 18-30 months and potential to add 80-120M CNY revenue per market at scale.
Exploring Ligeance Aerospace Technology Co.,Ltd. Investor Profile: Who's Buying and Why?

DCF model

Ligeance Aerospace Technology Co.,Ltd. (000697.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.